Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

The effectiveness and cost-effectiveness of the Incredible Years® Teacher Classroom Management programme in primary school children: results of the STARS cluster randomised controlled trial.

Ford T, Hayes R, Byford S, Edwards V, Fletcher M, Logan S, Norwich B, Pritchard W, Allen K, Allwood M, Ganguli P, Grimes K, Hansford L, Longdon B, Norman S, Price A, Ukoumunne OC.

Psychol Med. 2018 Jul 18:1-15. doi: 10.1017/S0033291718001484. [Epub ahead of print]

PMID:
30017006
2.

Comparison of effectiveness and cost-effectiveness of an intensive community supported discharge service versus treatment as usual for adolescents with psychiatric emergencies: a randomised controlled trial.

Ougrin D, Corrigall R, Poole J, Zundel T, Sarhane M, Slater V, Stahl D, Reavey P, Byford S, Heslin M, Ivens J, Crommelin M, Abdulla Z, Hayes D, Middleton K, Nnadi B, Taylor E.

Lancet Psychiatry. 2018 Jun;5(6):477-485. doi: 10.1016/S2215-0366(18)30129-9. Epub 2018 May 3.

3.

The cost of child and adolescent mental health services.

Skokauskas N, Lavelle TA, Munir K, Sampaio F, Nystrand C, McCrone P, McDaid D, Chisholm D, Byford S, Ganguli P, Feldman I, Belfer M.

Lancet Psychiatry. 2018 Apr;5(4):299-300. doi: 10.1016/S2215-0366(18)30089-0. No abstract available.

PMID:
29580605
4.

Accuracy of the Whooley questions and the Edinburgh Postnatal Depression Scale in identifying depression and other mental disorders in early pregnancy.

Howard LM, Ryan EG, Trevillion K, Anderson F, Bick D, Bye A, Byford S, O'Connor S, Sands P, Demilew J, Milgrom J, Pickles A.

Br J Psychiatry. 2018 Jan;212(1):50-56. doi: 10.1192/bjp.2017.9.

PMID:
29433610
5.

Multisystemic therapy versus management as usual in the treatment of adolescent antisocial behaviour (START): a pragmatic, randomised controlled, superiority trial.

Fonagy P, Butler S, Cottrell D, Scott S, Pilling S, Eisler I, Fuggle P, Kraam A, Byford S, Wason J, Ellison R, Simes E, Ganguli P, Allison E, Goodyer IM.

Lancet Psychiatry. 2018 Feb;5(2):119-133. doi: 10.1016/S2215-0366(18)30001-4. Epub 2018 Jan 5.

6.

Cost-effectiveness of cognitive therapy as an early intervention for post-traumatic stress disorder in children and adolescents: a trial based evaluation and model.

Shearer J, Papanikolaou N, Meiser-Stedman R, McKinnon A, Dalgleish T, Smith P, Dixon C, Byford S.

J Child Psychol Psychiatry. 2018 Jul;59(7):773-780. doi: 10.1111/jcpp.12851. Epub 2017 Dec 2.

PMID:
29197091
7.

The Association Between Child and Family Characteristics and the Mental Health and Wellbeing of Caregivers of Children with Autism in Mid-Childhood.

Salomone E, Leadbitter K, Aldred C, Barrett B, Byford S, Charman T, Howlin P, Green J, Le Couteur A, McConachie H, Parr JR, Pickles A, Slonims V; PACT Consortium.

J Autism Dev Disord. 2018 Apr;48(4):1189-1198. doi: 10.1007/s10803-017-3392-x.

8.

REFLECTIONS ON THE NICE DECISION TO REJECT PATIENT PRODUCTION LOSSES.

Shearer J, Byford S, Birch S.

Int J Technol Assess Health Care. 2017 Jan;33(6):638-643. doi: 10.1017/S0266462317000952. Epub 2017 Nov 20.

PMID:
29151390
9.

Preventing enduring behavioural problems in young children through early psychological intervention (Healthy Start, Happy Start): study protocol for a randomized controlled trial.

Ramchandani PG, O'Farrelly C, Babalis D, Bakermans-Kranenburg MJ, Byford S, Grimas ESR, Iles JE, van IJzendoorn MH, McGinley J, Phillips CM, Stein A, Warwick J, Watt HC, Scott S.

Trials. 2017 Nov 15;18(1):543. doi: 10.1186/s13063-017-2293-9.

10.

Cognitive-behaviour therapy for health anxiety in medical patients (CHAMP): a randomised controlled trial with outcomes to 5 years.

Tyrer P, Salkovskis P, Tyrer H, Wang D, Crawford MJ, Dupont S, Cooper S, Green J, Murphy D, Smith G, Bhogal S, Nourmand S, Lazarevic V, Loebenberg G, Evered R, Kings S, McNulty A, Lisseman-Stones Y, McAllister S, Kramo K, Nagar J, Reid S, Sanatinia R, Whittamore K, Walker G, Philip A, Warwick H, Byford S, Barrett B.

Health Technol Assess. 2017 Sep;21(50):1-58. doi: 10.3310/hta21500.

11.

Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.

Richards DA, Rhodes S, Ekers D, McMillan D, Taylor RS, Byford S, Barrett B, Finning K, Ganguli P, Warren F, Farrand P, Gilbody S, Kuyken W, O'Mahen H, Watkins E, Wright K, Reed N, Fletcher E, Hollon SD, Moore L, Backhouse A, Farrow C, Garry J, Kemp D, Plummer F, Warner F, Woodhouse R.

Health Technol Assess. 2017 Aug;21(46):1-366. doi: 10.3310/hta21460.

12.

Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive-compulsive disorder: the Obsessive-Compulsive Treatment Efficacy randomised controlled Trial (OCTET).

Lovell K, Bower P, Gellatly J, Byford S, Bee P, McMillan D, Arundel C, Gilbody S, Gega L, Hardy G, Reynolds S, Barkham M, Mottram P, Lidbetter N, Pedley R, Molle J, Peckham E, Knopp-Hoffer J, Price O, Connell J, Heslin M, Foley C, Plummer F, Roberts C.

Health Technol Assess. 2017 Jun;21(37):1-132. doi: 10.3310/hta21370.

13.

Low-intensity cognitive-behaviour therapy interventions for obsessive-compulsive disorder compared to waiting list for therapist-led cognitive-behaviour therapy: 3-arm randomised controlled trial of clinical effectiveness.

Lovell K, Bower P, Gellatly J, Byford S, Bee P, McMillan D, Arundel C, Gilbody S, Gega L, Hardy G, Reynolds S, Barkham M, Mottram P, Lidbetter N, Pedley R, Molle J, Peckham E, Knopp-Hoffer J, Price O, Connell J, Heslin M, Foley C, Plummer F, Roberts C.

PLoS Med. 2017 Jun 27;14(6):e1002337. doi: 10.1371/journal.pmed.1002337. eCollection 2017 Jun.

14.

The ward as emotional ecology: Adolescent experiences of managing mental health and distress in psychiatric inpatient settings.

Reavey P, Poole J, Corrigall R, Zundel T, Byford S, Sarhane M, Taylor E, Ivens J, Ougrin D.

Health Place. 2017 Jul;46:210-218. doi: 10.1016/j.healthplace.2017.05.008. Epub 2017 May 26.

PMID:
28554098
15.

The effectiveness and cost-effectiveness of a mindfulness training programme in schools compared with normal school provision (MYRIAD): study protocol for a randomised controlled trial.

Kuyken W, Nuthall E, Byford S, Crane C, Dalgleish T, Ford T, Greenberg MT, Ukoumunne OC, Viner RM, Williams JMG; MYRIAD team.

Trials. 2017 Apr 26;18(1):194. doi: 10.1186/s13063-017-1917-4.

16.

Cognitive-behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trial.

Goodyer IM, Reynolds S, Barrett B, Byford S, Dubicka B, Hill J, Holland F, Kelvin R, Midgley N, Roberts C, Senior R, Target M, Widmer B, Wilkinson P, Fonagy P.

Health Technol Assess. 2017 Mar;21(12):1-94. doi: 10.3310/hta21120.

17.

Assessing the validity of the ICECAP-A capability measure for adults with depression.

Mitchell PM, Al-Janabi H, Byford S, Kuyken W, Richardson J, Iezzi A, Coast J.

BMC Psychiatry. 2017 Feb 2;17(1):46. doi: 10.1186/s12888-017-1211-8.

18.

Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trial.

Marsden J, Stillwell G, Hellier J, Brown AM, Byford S, Kelleher M, Kelly J, Murphy C, Shearer J, Mitcheson L.

Contemp Clin Trials. 2017 Feb;53:36-43. doi: 10.1016/j.cct.2016.12.003. Epub 2016 Dec 8.

PMID:
27940188
19.

Cognitive behavioural therapy and short-term psychoanalytical psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled superiority trial.

Goodyer IM, Reynolds S, Barrett B, Byford S, Dubicka B, Hill J, Holland F, Kelvin R, Midgley N, Roberts C, Senior R, Target M, Widmer B, Wilkinson P, Fonagy P.

Lancet Psychiatry. 2017 Feb;4(2):109-119. doi: 10.1016/S2215-0366(16)30378-9. Epub 2016 Dec 1.

20.

Parent-mediated social communication therapy for young children with autism (PACT): long-term follow-up of a randomised controlled trial.

Pickles A, Le Couteur A, Leadbitter K, Salomone E, Cole-Fletcher R, Tobin H, Gammer I, Lowry J, Vamvakas G, Byford S, Aldred C, Slonims V, McConachie H, Howlin P, Parr JR, Charman T, Green J.

Lancet. 2016 Nov 19;388(10059):2501-2509. doi: 10.1016/S0140-6736(16)31229-6. Epub 2016 Oct 25.

21.

Depression: an exploratory parallel-group randomised controlled trial of Antenatal guided self help for WomeN (DAWN): study protocol for a randomised controlled trial.

Trevillion K, Domoney J, Pickles A, Bick D, Byford S, Heslin M, Milgrom J, Mycroft R, Pariante C, Ryan E, Hunter M, Howard LM.

Trials. 2016 Oct 18;17(1):503.

22.

The effectiveness, acceptability and cost-effectiveness of psychosocial interventions for maltreated children and adolescents: an evidence synthesis.

Macdonald G, Livingstone N, Hanratty J, McCartan C, Cotmore R, Cary M, Glaser D, Byford S, Welton NJ, Bosqui T, Bowes L, Audrey S, Mezey G, Fisher HL, Riches W, Churchill R.

Health Technol Assess. 2016 Sep;20(69):1-508. doi: 10.3310/hta20690. Review.

23.

Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.

Richards DA, Ekers D, McMillan D, Taylor RS, Byford S, Warren FC, Barrett B, Farrand PA, Gilbody S, Kuyken W, O'Mahen H, Watkins ER, Wright KA, Hollon SD, Reed N, Rhodes S, Fletcher E, Finning K.

Lancet. 2016 Aug 27;388(10047):871-80. doi: 10.1016/S0140-6736(16)31140-0. Epub 2016 Jul 23.

24.

Human trafficking and severe mental illness: an economic analysis of survivors' use of psychiatric services.

Cary M, Oram S, Howard LM, Trevillion K, Byford S.

BMC Health Serv Res. 2016 Jul 19;16:284. doi: 10.1186/s12913-016-1541-0.

25.

Clinical characteristics associated with the prescribing of SSRI medication in adolescents with major unipolar depression.

Cousins L, Whitaker KJ, Widmer B, Midgley N, Byford S, Dubicka B, Kelvin R, Reynolds S, Roberts C, Holland F, Barrett B, Senior R, Wilkinson P, Target M, Fonagy P, Goodyer IM.

Eur Child Adolesc Psychiatry. 2016 Dec;25(12):1287-1295. Epub 2016 Apr 28.

26.

Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized Trials.

Kuyken W, Warren FC, Taylor RS, Whalley B, Crane C, Bondolfi G, Hayes R, Huijbers M, Ma H, Schweizer S, Segal Z, Speckens A, Teasdale JD, Van Heeringen K, Williams M, Byford S, Byng R, Dalgleish T.

JAMA Psychiatry. 2016 Jun 1;73(6):565-74. doi: 10.1001/jamapsychiatry.2016.0076.

PMID:
27119968
27.

An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence.

Rafia R, Dodd PJ, Brennan A, Meier PS, Hope VD, Ncube F, Byford S, Tie H, Metrebian N, Hellier J, Weaver T, Strang J.

Addiction. 2016 Sep;111(9):1616-27. doi: 10.1111/add.13385. Epub 2016 May 6.

28.

Decision analytic model exploring the cost and cost-offset implications of street triage.

Heslin M, Callaghan L, Packwood M, Badu V, Byford S.

BMJ Open. 2016 Feb 11;6(2):e009670. doi: 10.1136/bmjopen-2015-009670.

29.

Cost-effectiveness analysis of a communication-focused therapy for pre-school children with autism: results from a randomised controlled trial.

Byford S, Cary M, Barrett B, Aldred CR, Charman T, Howlin P, Hudry K, Leadbitter K, Le Couteur A, McConachie H, Pickles A, Slonims V, Temple KJ, Green J; PACT Consortium.

BMC Psychiatry. 2015 Dec 21;15:316. doi: 10.1186/s12888-015-0700-x.

30.

Evaluation of multisystemic therapy pilot services in Services for Teens Engaging in Problem Sexual Behaviour (STEPS-B): study protocol for a randomized controlled trial.

Fonagy P, Butler S, Baruch G, Byford S, Seto MC, Wason J, Wells C, Greisbach J, Ellison R, Simes E.

Trials. 2015 Nov 2;16:492. doi: 10.1186/s13063-015-1017-2.

31.

The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study).

Kuyken W, Hayes R, Barrett B, Byng R, Dalgleish T, Kessler D, Lewis G, Watkins E, Morant N, Taylor RS, Byford S.

Health Technol Assess. 2015 Sep;19(73):1-124. doi: 10.3310/hta19730.

32.

Clinical effectiveness and cost-effectiveness of tailored intensive liaison between primary and secondary care to identify individuals at risk of a first psychotic illness (the LEGs study): a cluster-randomised controlled trial.

Perez J, Jin H, Russo DA, Stochl J, Painter M, Shelley G, Jackson E, Crane C, Graffy JP, Croudace TJ, Byford S, Jones PB.

Lancet Psychiatry. 2015 Nov;2(11):984-93. doi: 10.1016/S2215-0366(15)00157-1. Epub 2015 Aug 19.

33.

Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluation.

Crawford MJ, Sanatinia R, Barrett B, Byford S, Cunningham G, Gakhal K, Lawrence-Smith G, Leeson V, Lemonsky F, Lykomitrou G, Montgomery A, Morriss R, Paton C, Tan W, Tyrer P, Reilly JG.

Trials. 2015 Jul 18;16:308. doi: 10.1186/s13063-015-0823-x.

34.

Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial.

Kuyken W, Hayes R, Barrett B, Byng R, Dalgleish T, Kessler D, Lewis G, Watkins E, Brejcha C, Cardy J, Causley A, Cowderoy S, Evans A, Gradinger F, Kaur S, Lanham P, Morant N, Richards J, Shah P, Sutton H, Vicary R, Weaver A, Wilks J, Williams M, Taylor RS, Byford S.

Lancet. 2015 Jul 4;386(9988):63-73. doi: 10.1016/S0140-6736(14)62222-4. Epub 2015 Apr 20.

35.

Understanding influences on teachers' uptake and use of behaviour management strategies within the STARS trial: process evaluation protocol for a randomised controlled trial.

Hansford L, Sharkey S, Edwards V, Ukoumunne O, Byford S, Norwich B, Logan S, Ford T.

BMC Public Health. 2015 Feb 10;15:119. doi: 10.1186/s12889-015-1486-y.

36.

Economic evaluations of contingency management in illicit drug misuse programmes: A systematic review.

Shearer J, Tie H, Byford S.

Drug Alcohol Rev. 2015 May;34(3):289-98. doi: 10.1111/dar.12240. Epub 2015 Feb 8. Review.

PMID:
25659953
37.

Telephone cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: a randomized controlled non-inferiority trial.

Turner CM, Mataix-Cols D, Lovell K, Krebs G, Lang K, Byford S, Heyman I.

J Am Acad Child Adolesc Psychiatry. 2014 Dec;53(12):1298-1307.e2. doi: 10.1016/j.jaac.2014.09.012. Epub 2014 Sep 30.

38.

Obsessive Compulsive Treatment Efficacy Trial (OCTET) comparing the clinical and cost effectiveness of self-managed therapies: study protocol for a randomised controlled trial.

Gellatly J, Bower P, McMillan D, Roberts C, Byford S, Bee P, Gilbody S, Arundel C, Hardy G, Barkham M, Reynolds S, Gega L, Mottram P, Lidbetter N, Pedley R, Peckham E, Connell J, Molle J, O'Leary N, Lovell K.

Trials. 2014 Jul 10;15:278. doi: 10.1186/1745-6215-15-278.

39.

The clinical and cost-effectiveness of brief advice for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial.

Crawford MJ, Sanatinia R, Barrett B, Byford S, Dean M, Green J, Jones R, Leurent B, Sweeting MJ, Touquet R, Greene L, Tyrer P, Ward H, Lingford-Hughes A.

Sex Transm Infect. 2015 Feb;91(1):37-43. doi: 10.1136/sextrans-2014-051561. Epub 2014 Jun 16.

40.

Update to the study protocol for a randomized controlled trial comparing mindfulness-based cognitive therapy with maintenance anti-depressant treatment depressive relapse/recurrence: the PREVENT trial.

Kuyken W, Byford S, Byng R, Dalgleish T, Lewis G, Taylor R, Watkins ER, Hayes R, Lanham P, Kessler D, Morant N, Evans A.

Trials. 2014 Jun 10;15:217. doi: 10.1186/1745-6215-15-217.

41.

Comparing service use and costs among adolescents with autism spectrum disorders, special needs and typical development.

Barrett B, Mosweu I, Jones CR, Charman T, Baird G, Simonoff E, Pickles A, Happé F, Byford S.

Autism. 2015 Jul;19(5):562-9. doi: 10.1177/1362361314536626. Epub 2014 Jun 9.

PMID:
24913778
42.

A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures.

Brazier J, Connell J, Papaioannou D, Mukuria C, Mulhern B, Peasgood T, Jones ML, Paisley S, O'Cathain A, Barkham M, Knapp M, Byford S, Gilbody S, Parry G.

Health Technol Assess. 2014 May;18(34):vii-viii, xiii-xxv, 1-188. doi: 10.3310/hta18340. Review.

43.

Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D.

Mulhern B, Mukuria C, Barkham M, Knapp M, Byford S, Soeteman D, Brazier J.

Br J Psychiatry. 2014 Sep;205(3):236-43. doi: 10.1192/bjp.bp.112.122283. Epub 2014 May 22.

PMID:
24855127
44.

The clinical effectiveness and cost-effectiveness of brief intervention for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial (SHEAR).

Crawford MJ, Sanatinia R, Barrett B, Byford S, Dean M, Green J, Jones R, Leurent B, Lingford-Hughes A, Sweeting M, Touquet R, Tyrer P, Ward H.

Health Technol Assess. 2014 May;18(30):1-48. doi: 10.3310/hta18300.

45.

Authors' reply.

Byford S, Barrett B, Metrebian N, Groshkova T, Cary M, Charles V, Lintzeris N, Strang J.

Br J Psychiatry. 2014 Mar;204(3):241-2. doi: 10.1192/bjp.204.3.241a. No abstract available.

PMID:
24590978
46.

The clinical effectiveness, cost-effectiveness and acceptability of community-based interventions aimed at improving or maintaining quality of life in children of parents with serious mental illness: a systematic review.

Bee P, Bower P, Byford S, Churchill R, Calam R, Stallard P, Pryjmachuk S, Berzins K, Cary M, Wan M, Abel K.

Health Technol Assess. 2014 Feb;18(8):1-250. doi: 10.3310/hta18080. Review.

47.

Cost and outcome of behavioural activation versus cognitive behaviour therapy for depression (COBRA): study protocol for a randomised controlled trial.

Rhodes S, Richards DA, Ekers D, McMillan D, Byford S, Farrand PA, Gilbody S, Hollon SD, Kuyken W, Martell C, O'Mahen HA, O'Neill E, Reed N, Taylor RS, Watkins ER, Wright KA.

Trials. 2014 Jan 21;15:29. doi: 10.1186/1745-6215-15-29.

48.

Randomised controlled trial of joint crisis plans to reduce compulsory treatment for people with psychosis: economic outcomes.

Barrett B, Waheed W, Farrelly S, Birchwood M, Dunn G, Flach C, Henderson C, Leese M, Lester H, Marshall M, Rose D, Sutherby K, Szmukler G, Thornicroft G, Byford S.

PLoS One. 2013 Nov 25;8(11):e74210. doi: 10.1371/journal.pone.0074210. eCollection 2013.

49.

Clinical and cost-effectiveness of cognitive behaviour therapy for health anxiety in medical patients: a multicentre randomised controlled trial.

Tyrer P, Cooper S, Salkovskis P, Tyrer H, Crawford M, Byford S, Dupont S, Finnis S, Green J, McLaren E, Murphy D, Reid S, Smith G, Wang D, Warwick H, Petkova H, Barrett B.

Lancet. 2014 Jan 18;383(9913):219-25. doi: 10.1016/S0140-6736(13)61905-4. Epub 2013 Oct 18. Erratum in: Lancet. 2014 Jan 18;383(9913):218.

PMID:
24139977
50.

Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.

Byford S, Barrett B, Metrebian N, Groshkova T, Cary M, Charles V, Lintzeris N, Strang J.

Br J Psychiatry. 2013 Nov;203(5):341-9. doi: 10.1192/bjp.bp.112.111583. Epub 2013 Sep 12.

PMID:
24029536

Supplemental Content

Loading ...
Support Center